LungLife AI Inc (LLAI) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.245x

Based on the latest financial reports, LungLife AI Inc (LLAI) has a cash flow conversion efficiency ratio of -0.245x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.94 Million ≈ $-236.53 USD) by net assets (GBX7.93 Million ≈ $965.22 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of LungLife AI Inc to measure how much of total assets are equity-financed.

LungLife AI Inc - Cash Flow Conversion Efficiency Trend (2018–2023)

This chart illustrates how LungLife AI Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can LungLife AI Inc service its debt to assess how comfortably operating cash covers total debt obligations.

LungLife AI Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LungLife AI Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Endor AG MU:E2N	691.016x
ECD Automotive Design Inc NASDAQ:ECDA	0.126x
Worldsec Ltd LSE:WSL	-0.052x
Nostra Terra Oil and Gas Company PLC LSE:NTOG	0.205x
Cloudcoco Group PLC LSE:CLCO	-2.129x
Gunsynd PLC LSE:GUN	-0.112x
Orient Europharma Co Ltd TWO:4120	-0.020x
CRESTVIEW EXPLORATION INC F:CE7	N/A

Annual Cash Flow Conversion Efficiency for LungLife AI Inc (2018–2023)

The table below shows the annual cash flow conversion efficiency of LungLife AI Inc from 2018 to 2023. For the full company profile with market capitalisation and key ratios, see LungLife AI Inc (LLAI) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	GBX7.91 Million ≈ $962.78	GBX-5.02 Million ≈ $-610.79	-0.634x	-42.62%
2022-12-31	GBX13.14 Million ≈ $1.60K	GBX-5.84 Million ≈ $-711.17	-0.445x	-18.78%
2021-12-31	GBX20.13 Million ≈ $2.45K	GBX-7.54 Million ≈ $-917.26	-0.375x	-154.46%
2020-12-31	GBX19.53 Million ≈ $2.38K	GBX-2.87 Million ≈ $-349.69	-0.147x	-130.12%
2019-12-31	GBX-6.80 Million ≈ $-827.11	GBX-3.32 Million ≈ $-404.19	0.489x	-29.30%
2018-12-31	GBX-3.10 Million ≈ $-377.22	GBX-2.14 Million ≈ $-260.72	0.691x	--

About LungLife AI Inc

LSE:LLAI UK Diagnostics & Research

Market Cap

$15.48K

GBX127.23 Million GBX

Market Cap Rank

#31635 Global

#1276 in UK

Share Price

GBX4.15

Change (1 day)

+0.00%

52-Week Range

GBX4.15 - GBX4.15

All Time High

GBX205.00